Day: November 24, 2025
CHARLOTTE, N.C., Nov. 24, 2025 (GLOBE NEWSWIRE) — Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), the parent company of IM8 and a global health-tech and longevity company pioneering a dual-engine strategy across consumer wellness and Bitcoin, today announced that all key members of its executive leadership team have executed open market purchases of Prenetics’ common stock during the Company’s designated trading window.
In total, the executive team acquired 111,911 shares of Prenetics’ common stock for an aggregate purchase price of approximately $1,446,887.
Individual Transaction Details
Danny Yeung, Chief Executive OfficerIn two open market transactions on November 18 and 19, Mr. Yeung acquired a total of 40,118 shares for a total purchase price of approximately $502,000, at an average...
Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting
Written by Customer Service on . Posted in Public Companies.
Record-setting presence at ASH reflects widespread recognition of clonoSEQ as a standard-of-care tool for personalizing patient care and accelerating drug development
SEATTLE, Nov. 24, 2025 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, announced that its next-generation sequencing (NGS)-based clonoSEQ® test for measurable residual disease (MRD) assessment will be included in 89 abstracts, including 36 oral presentations, at the 67th Annual Meeting of the American Society of Hematology (ASH) taking place Dec. 6–9, 2025, in Orlando.
Key highlights include:Abstracts featuring clonoSEQ MRD data span multiple myeloma (MM), acute lymphoblastic leukemia...
Biogen and Dayra Therapeutics Announce Research Collaboration to Discover and Develop Oral Macrocyclic Peptides for a Range of Immunological Conditions
Written by Customer Service on . Posted in Public Companies.
Oral macrocyclic peptides have the potential to offer biologic-like efficacy and safety in a convenient oral format
Collaboration further advances Biogen’s immunology strategy by broadening its early-stage pipeline and incorporating an additional clinically validated modality into its expanding immunology capabilitiesCAMBRIDGE, Mass. and TORONTO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) and Dayra Therapeutics today announced a research collaboration to discover and develop oral macrocyclic peptides for priority targets in immunological conditions. Macrocyclic peptides have a unique profile with the potential to offer biologic-like efficacy and safety in an oral format, potentially disrupting established antibody-based treatments. The collaboration enhances Biogen’s strategy to build a differentiated immunology...
GXO Announces Completion of Inaugural European Bond Offering
Written by Customer Service on . Posted in Public Companies.
GREENWICH, Conn., Nov. 24, 2025 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, today announced the completion of its inaugural European bond offering, with its wholly owned subsidiary GXO Logistics Capital B.V. issuing €500m in senior unsecured notes (the “notes”). The notes will bear interest at a rate of 3.750% per annum payable annually, commencing November 24, 2026, and will mature on November 24, 2030.
“The successful close of our first European bond offering is a milestone for GXO as an investment-grade issuer and underscores investor confidence in our business,” said Baris Oran, Chief Financial Officer, GXO. “By securing €500m on competitive terms and using the proceeds to refinance upcoming maturities, we are strengthening our balance sheet and positioning...
Antalpha Announces $10 Million Share Repurchase Program
Written by Customer Service on . Posted in Public Companies.
SINGAPORE, Nov. 24, 2025 (GLOBE NEWSWIRE) — Antalpha Platform Holding Company (NASDAQ: ANTA) (“Antalpha” or the “Company”) today announced that its board of directors has authorized a share repurchase program of up to $10 million of the Company’s ordinary shares. The program will remain in effect through December 31, 2026.
“Antalpha has delivered strong operating momentum, with accelerating revenue growth, expanding margins, and growing institutional interest in our ability to leverage over-collateralization and other risk-management measures to provide clients with liquidity that helps them navigate crypto volatility. This performance gives us the financial flexibility to execute a share repurchase program that we believe will deliver more value to shareholders,” said Paul Liang, CFO of Antalpha. “Our anchor...
Cannara Biotech Delivers Record Fiscal 2025 Revenue and Profitability, Achieves First Year of Positive Retained Earnings
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Record Fiscal 2025 Financial Performance: Record net revenues of $107.3 million, adjusted EBITDA of $28.1 million1, net income of $13.1 million, operating cash flow of $20 million and free cash flow of $13.7 million1 for Fiscal 2025.
Stronger Balance Sheet and Earnings Quality: First year of positive retained earnings as at August 31, 2025, supported by continued free cash flow generation and lower leverage.
Continued Market Share Expansion: National market share rose to 3.81% in Fiscal 2025, up 32% year over year, and climbed further to 4.1% in October 20252.
Annual General Meeting of shareholders scheduled for January 29, 2026, at 11:00 a.m. EST.All financial results are reported in Canadian dollars, unless otherwise stated.
MONTREAL, Nov. 24, 2025 (GLOBE NEWSWIRE) — Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or...
Gaming and Leisure Properties, Inc. Declares Fourth Quarter 2025 Cash Dividend of $0.78 Per Share
Written by Customer Service on . Posted in Dividend Reports And Estimates.
WYOMISSING, Pa., Nov. 24, 2025 (GLOBE NEWSWIRE) — Gaming and Leisure Properties, Inc. (NASDAQ: GLPI) (“GLPI” or the “Company”), announced today that the Company’s Board of Directors has declared the fourth quarter 2025 cash dividend of $0.78 per share of its common stock. The dividend is payable on December 19, 2025 to shareholders of record on December 5, 2025. Based on GLPI’s closing share price of $43.04 on November 21, the current dividend, on an annualized basis, reflects a yield of 7.25%. The fourth quarter 2024 cash dividend was $0.76 per share of the Company’s common stock.
While the Company intends to pay regular quarterly cash dividends for the foreseeable future, all subsequent dividends will be reviewed quarterly and declared by the Board of Directors at its discretion.
About Gaming and Leisure Properties
GLPI is engaged...
Osisko Development Announces Agreement to Divest Non-Core San Antonio Gold Project
Written by Customer Service on . Posted in Public Companies.
MONTREAL, Nov. 24, 2025 (GLOBE NEWSWIRE) — Osisko Development Corp. (NYSE: ODV, TSXV: ODV) (“Osisko Development” or the “Company“) is pleased to announce that it has entered into a securities purchase agreement dated November 21, 2025 (the “Purchase Agreement“) with Axo Copper Corp. (TSXV:AXO) (“Axo“) to sell its 100% interest in the San Antonio Gold Project (“San Antonio” or the “Project“) located in the Sonora State, Mexico. Pursuant to the Purchase Agreement, Axo will acquire Sapuchi Minera S.A. de R.L. de C.V. (“Sapuchi“), which holds a 100% interest in the mineral concessions comprising San Antonio, subject to the satisfaction of certain conditions (the “Transaction“).
Upon closing of the Transaction, Osisko Development will receive,...
Chijet Motor Company Enters Strategic Partnership with EdgeAI Frontier Technology Ltd. to Acquire Up to $1 Billion in EdgeAI Tokens at a 20% Discount
Written by Customer Service on . Posted in Public Companies.
New York, Nov. 24, 2025 (GLOBE NEWSWIRE) — CHIJET MOTOR COMPANY, INC. (NASDAQ: CJET) (“Chijet” or the “Company”), is pleased to announce that it has signed a definitive agreement (the “Agreement”) with EdgeAI Frontier Technology Ltd. (“EdgeAI”) to acquire up to $1 billion in EdgeAI tokens at an exclusive 20% discount to prevailing market prices. The Agreement builds on the previously announced strategic alignment and represents a meaningful expansion of the partnership into the digital asset space, delivering immediate economic benefits while positioning Chijet as a meaningful participant in decentralized intelligence and blockchain-enabled technologies.
The discounted purchase structure is expected to generate approximately $200 million in upfront value for Chijet relative to current market rates, while establishing a robust cryptocurrency...
Green Rain Energy Holdings (OTCID: $GREH) Launches Regulation Crowdfunding for Its Subsidiary Green Rain Development
Written by Customer Service on . Posted in Public Companies.
Green Rain Energy Holdings (OTCID: $GREH) Launches Regulation Crowdfunding for Its Subsidiary Green Rain DevelopmentGreen Rain Energy Holdings Inc. (OTCID: $GREH) is excited to announce the initiation of Regulation Crowdfunding (Reg CF) through its wholly owned subsidiary, Green Rain Development.BEVERLY HILLS, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) — Green Rain Energy Holdings Inc. (OTCID: $GREH) is excited to announce the initiation of Regulation Crowdfunding (Reg CF) through its wholly owned subsidiary, Green Rain Development. This strategic move enables the company to raise capital by offering fractional ownership to a broad range of investors, granting them access to revenue streams and incentive-based rebates.
Reg CF represents a significant step toward democratizing investment opportunities in clean energy. By leveraging...
